Patents by Inventor Satoko Yamazaki

Satoko Yamazaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230313204
    Abstract: The present invention provides an aptamer that binds to chymase, and contains a common sequence represented by UAACR1N1R2GGGG wherein R1 and R2 are each any one base, and N1 shows 3 to 30 bases (uracil is optionally thymine).
    Type: Application
    Filed: April 3, 2023
    Publication date: October 5, 2023
    Applicant: RIBOMIC INC.
    Inventors: Satoko YAMAZAKI, Yosuke NONAKA, Yoshikazu NAKAMURA, Masahiro MURAGUCHI, Kaori MURATA
  • Patent number: 11639503
    Abstract: The present invention provides an aptamer that binds to chymase, and contains a common sequence represented by UAACR1N1R2GGGG wherein R1 and R2 are each any one base, and N1 shows 3 to 30 bases (uracil is optionally thymine).
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: May 2, 2023
    Assignee: RIBOMIC INC.
    Inventors: Satoko Yamazaki, Yosuke Nonaka, Yoshikazu Nakamura, Masahiro Muraguchi, Kaori Murata
  • Publication number: 20210002644
    Abstract: The present invention provides an aptamer that binds to chymase, and contains a common sequence represented by UAACR1N1R2GGGG wherein R1 and R2 are each any one base, and N1 shows 3 to 30 bases (uracil is optionally thymine).
    Type: Application
    Filed: November 30, 2018
    Publication date: January 7, 2021
    Applicant: RIBOMIC INC.
    Inventors: Satoko YAMAZAKI, Yosuke NONAKA, Yoshikazu NAKAMURA, Masahiro MURAGUCHI, Kaori MURATA
  • Patent number: 9012420
    Abstract: Provided are an aptamer bound to chymase to inhibit activity of chymase; an aptamer containing a nucleotide sequence represented by X1GAUAGAN1N2UAAX2 wherein X1 and X2 are the same or different and each is A or G, and N1 and N2 are the same or different and each is A, G, C, U or T; a complex containing the aptamer and a functional substance (e.g., affinity substance, labeling substance, enzyme, drug delivery medium, drug and the like); a pharmaceutical or a reagent containing the aptamer or complex; a detection and a purification methods of chymase using the aptamer or complex and the like.
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: April 21, 2015
    Assignees: Ribomic Inc., Otsuka Pharmaceutical Co., Ltd.
    Inventors: Yoshikazu Nakamura, Ling Jin, Satoko Yamazaki, Hisako Ikeda, Masahiro Muraguchi
  • Publication number: 20120165401
    Abstract: Provided are an aptamer bound to chymase to inhibit activity of chymase; an aptamer containing a nucleotide sequence represented by X1GAUAGAN1N2UAAX2 wherein X1 and X2 are the same or different and each is A or G, and N1 and N2 are the same or different and each is A, G, C, U or T; a complex containing the aptamer and a functional substance (e.g., affinity substance, labeling substance, enzyme, drug delivery medium, drug and the like); a pharmaceutical or a reagent containing the aptamer or complex; a detection and a purification methods of chymase using the aptamer or complex and the like.
    Type: Application
    Filed: June 11, 2010
    Publication date: June 28, 2012
    Inventors: Yoshikazu Nakamura, Ling Jin, Satoko Yamazaki, Hisako Ikeda, Masahiro Muraguchi